Two of primary buyout specialists Kester Capital’s portfolio companies, Rephine and Jollyes, have completed strategic acquisitions.
In addition, Kester has provided follow-on funding to another portfolio company, Optibrium, to accelerate development and expansion.
This investment activity comes on the back of the recent sale of Avania, which delivered in excess of 8x ROI for Kester.
Rephine, a leading provider of Good Manufacturing Practice (GMP) audits and regulatory consulting services to the pharmaceutical industry, has acquired Barcelona-based GxP audit organisation Forum Auditorias, and its manufacturing supply chain compliance consultancy TDV. Jollyes, meanwhile, a UK retailer of specialty pet products, has completed the acquisition of Penparc, a chain of pet retail stores across the Midlands. The acquisition of Penparc follows Jollyes’ acquisition of The Pet Store and Bannerbrook Pets in 2021.
Optibrium, a provider of drug discovery software to the pharmaceutical and biotech industries, has also secured further investment from Kester.
